Modulation of HERG potassium channels by extracellular magnesium and quinidine.
暂无分享,去创建一个
P. Bennett | D W Wang | P B Bennett | S. Po | D. W. Wang | I. Yang | J. Johnson | L. Nie | S S Po | I C Yang | J P Johnson | L Nie
[1] B. Hille,et al. Negative surface charge near sodium channels of nerve: divalent ions, monovalent ions, and pH. , 1975, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[2] H. Strauss,et al. Modulation of HERG affinity for E‐4031 by [K+]o and C‐type inactivation , 1997, FEBS letters.
[3] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[4] Voltage‐ and time‐dependent block of delayed rectifier K+ current in rabbit sino‐atrial node cells by external Ca2+ and Mg2+. , 1996, The Journal of physiology.
[5] A. Moss,et al. The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.
[6] R. Tsien,et al. Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+. Voltage and concentration dependence of calcium entry into the pore , 1986, The Journal of general physiology.
[7] G. Landes,et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.
[8] A. Moss. Molecular genetics and ventricular arrhythmias. , 1992, The New England journal of medicine.
[9] P. Hess,et al. Block of the L‐type Ca2+ channel pore by external and internal Mg2+ in rat phaeochromocytoma cells. , 1993, The Journal of physiology.
[10] A. Brown,et al. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. , 1996, Circulation.
[11] D. Snyders,et al. Effects of quinidine on the sodium current of guinea pig ventricular myocytes. Evidence for a drug-associated rested state with altered kinetics. , 1990, Circulation research.
[12] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.
[13] M. Sanguinetti,et al. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Sanguinetti,et al. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.
[15] D. Melton,et al. In vitro RNA synthesis with SP6 RNA polymerase. , 1987, Methods in enzymology.
[16] R Lazzara,et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.
[17] D. Roden. Risks and benefits of antiarrhythmic therapy. , 1994, The New England journal of medicine.
[18] A. Moss,et al. Clinical Aspects of the Idiopathic Long QT Syndrome a , 1992, Annals of the New York Academy of Sciences.
[19] R. Lazzara. Antiarrhythmic drugs and torsade de pointes. , 1993, European heart journal.
[20] P. Schwartz,et al. Evidence of Genetic Heterogeneity in Romano‐Ward Long QT syndrome: Analysis of 23 Families , 1994, Circulation.
[21] D. Roden,et al. Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. , 1991, Circulation research.
[22] S. Priori,et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.
[23] D. Snyders,et al. A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression , 1993, The Journal of general physiology.
[24] J. Seidman,et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. , 1996, Circulation.
[25] A. Keren,et al. Magnesium Therapy in Ventricular Arrhythmias , 1990, Pacing and clinical electrophysiology : PACE.
[26] A. Keren,et al. TORSADE DE POINTES: DEFINITIONS, CAUSATIVE FACTORS, AND THERAPY: EXPERIENCE WITH SIXTEEN PATIENTS , 1984, Annals of the New York Academy of Sciences.
[27] Lippincott Williams Wilkins,et al. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. , 1991, Circulation.
[28] A. Keren,et al. Treatment of torsade de pointes with magnesium sulfate. , 1988, Circulation.
[29] H. Strauss,et al. A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes , 1997, The Journal of physiology.
[30] J. Garcia-Rubira,et al. Magnesium sulphate for torsade de pointes in a patient with congenital long QT syndrome. , 1990, International journal of cardiology.
[31] S. Roberds,et al. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. , 1992, Molecular pharmacology.
[32] S. Priori,et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. , 1995, Human molecular genetics.
[33] D. Snyders,et al. Functional expression of an inactivating potassium channel cloned from human heart. , 1992, Circulation research.
[34] A. George,et al. Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.
[35] D. Roden. Clinical features of arrhythmia aggravation by antiarrhythmic drugs and their implications for basic mechanisms , 1990 .
[36] S. Roberds,et al. Heteromultimeric assembly of human potassium channels. Molecular basis of a transient outward current? , 1993, Circulation research.
[37] Gary Yellen,et al. The inward rectification mechanism of the HERG cardiac potassium channel , 1996, Nature.
[38] M. Leppert,et al. Locus heterogeneity of autosomal dominant long QT syndrome. , 1993, The Journal of clinical investigation.
[39] J. Warmke,et al. A family of potassium channel genes related to eag in Drosophila and mammals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] S Nattel,et al. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. , 1993, Circulation research.
[41] D. Zipes,et al. Torsades de pointes and proarrhythmia , 1993, The Lancet.
[42] A. Keren,et al. Magnesium therapy for torsades de pointes. , 1984, The American journal of cardiology.
[43] S. Heinemann,et al. Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. , 1996, The Journal of physiology.
[44] M. Sanguinetti,et al. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. , 1996, Circulation research.
[45] C. Schuger,et al. Treatment of torsade de pointes with intravenous magnesium. , 1989, The American journal of cardiology.